Julie Messersmith, Executive Director for Research at Johns Hopkins, discusses her roles in the strategies involved in bringing multi-disciplinary researchers together to work on COVID-19 and SARS-CoV-2. She shares information about the program for coordinated response with 9 working groups that were formed shortly after Hopkins shut down non essential work and research. She also discusses testing at Hopkins, genomics work on both the virus and hosts, and possible treatments in de...
All content for The Genomics Life is the property of Kelly Moffat and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Julie Messersmith, Executive Director for Research at Johns Hopkins, discusses her roles in the strategies involved in bringing multi-disciplinary researchers together to work on COVID-19 and SARS-CoV-2. She shares information about the program for coordinated response with 9 working groups that were formed shortly after Hopkins shut down non essential work and research. She also discusses testing at Hopkins, genomics work on both the virus and hosts, and possible treatments in de...
Dr. Elodie Ghedin on the covid-19 (coronavirus) pandemic
The Genomics Life
42 minutes
5 years ago
Dr. Elodie Ghedin on the covid-19 (coronavirus) pandemic
In a special episode, I speak to Elodie Ghedin about the pandemic and global health crisis we are facing. Elodie is a virologist and professor at NYU in Biology and Global Public Health. She studies microbial pathogens including human parasites and viruses and has done extensive work with influenza and other RNA viruses. In this episode we talk about the coronavirus that causes covid-19, from its emergence at the end of 2019 to the current crisis, and hopes for future treatments and vaccines....
The Genomics Life
Julie Messersmith, Executive Director for Research at Johns Hopkins, discusses her roles in the strategies involved in bringing multi-disciplinary researchers together to work on COVID-19 and SARS-CoV-2. She shares information about the program for coordinated response with 9 working groups that were formed shortly after Hopkins shut down non essential work and research. She also discusses testing at Hopkins, genomics work on both the virus and hosts, and possible treatments in de...
